Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New Demands Edge Closer for Clinical Trial Safety Reporting in the EU

This article was originally published in RAJ Devices

Executive Summary

The implementation deadline of 21 March has gone by and new safety reporting requirements for clinical investigations are now in place throughout the European Union.

You may also be interested in...



New Demands Edge Closer for Clinical Trial Safety Reporting in the EU

The implementation deadline of 21 March has gone by and new safety reporting requirements for clinical investigations are now in place throughout the European Union.

The 2009 Revision of ISO 14155: A True Worldwide Guidance for Medical Device Companies?

ISO 14155, the international standard covering medical device clinical investigation, has had its controversies over the past two years. An immature revision was brought out in 2008 and was subsequently voted down by many European Union countries; when it emerged that it had attracted no fewer than 1,100 comments, it was clear that something was wrong.

The 2009 Revision of ISO 14155: A True Worldwide Guidance for Medical Device Companies?

ISO 14155, the international standard covering medical device clinical investigation, has had its controversies over the past two years. An immature revision was brought out in 2008 and was subsequently voted down by many European Union countries; when it emerged that it had attracted no fewer than 1,100 comments, it was clear that something was wrong.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC096075

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel